The 2008 World Health Organization (WHO) classification defined Waldenström macroglobulinemia (WM) as a clinicopathologic entity associated with an IgM monoclonal gammopathy and marrow involvement, which is the commonest manifestation of LPL.[10] The pathogenesis of LPL is incompletely understood. The gene discussed is LPL; the disease is monoclonal gammopathy.